Periodic Reporting for period 1 - FrEBT (Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device)

Summary
During Phase1 of Horizon2020 SME Instrument, Comac Medical examined the novelty and commercialization potential of the validation of single breath Fractional Exhaled Breath Temperature biomarker through new method and medical device. The SME proved through patentability and...
More information & hyperlinks
Web resources: http://comac-medical.com/